EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lupeol-3-carbamate Derivatives: Synthesis and Biological Evaluation as Potential Antitumor Agents

Shuang Tian, Yinxu Zhao, Siqi Deng, Liman Hou, Juan Song, Ming Wang, Ming Bu iD

Molecules · 2024

DOI: 10.3390/molecules29173990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Shuang Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Pentacyclic Triterpenes, Cell Proliferation, Apoptosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qiqihar Science and Technology Bureau of China, Postdoc-toral Research Project of Heilongjiang Province, Postdoctoral Research Project of Heilongjiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the following study, a series of new lupeol-3-carbamate derivatives were synthesized, and the structures of all the newly derived compounds were characterized. The new compounds were screened to determine their anti-proliferative activity against human lung cancer cell line A549, human liver cancer cell line HepG2, and human breast cancer cell line MCF-7. Most of the compounds were found to show better anti-proliferative activity in vitro than lupeol. Among them, obvious anti-proliferation activity (IC50 = 5.39~9.43 μM) was exhibited by compound 3i against all three tumor cell lines. In addition, a salt reaction was performed on compound 3k (IC50 = 13.98 μM) and it was observed that the anti-proliferative activity and water solubility of compound 3k·CH3I (IC50 = 3.13 μM), were significantly enhanced subsequent to the salt formation process. The preliminary mechanistic studies demonstrated that apoptosis in HepG2 cells was induced by compound 3k·CH3I through the inhibition of the PI3K/AKT/mTOR pathway. In conclusion, a series of new lupeol-3-carbamate derivatives were synthesized via the structural modification of the C-3 site of lupeol, thus laying a theoretical foundation for the design of this new anticancer drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPentacyclic TriterpenesCell ProliferationApoptosisCarbamatesHumansHep G2 CellsStructure-Activity RelationshipCell Line, TumorDrug Screening Assays, AntitumorA549 CellsMCF-7 CellsProto-Oncogene Proteins c-aktMolecular StructurePhosphatidylinositol 3-KinasesSignal TransductionTOR Serine-Threonine KinasesLupanes

Stichwörter der Autor:innen

antitumorcarbamatehybridlupeolstructural modification

Substanzen

Antineoplastic AgentsPentacyclic TriterpenesCarbamateslupeolProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesLupanes

Autor:innen und Institutionen

  • College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China.

ORCID-Profile: Ming Bu

Förderung

  • Qiqihar Science and Technology Bureau of China
  • Postdoc-toral Research Project of Heilongjiang Province
  • Postdoctoral Research Project of Heilongjiang Province

Zitieren

APA

Tian, S., Zhao, Y., Deng, S., Hou, L., Song, J., Wang, M., & Bu, M. (2024). Lupeol-3-carbamate Derivatives: Synthesis and Biological Evaluation as Potential Antitumor Agents. Molecules. https://doi.org/10.3390/molecules29173990

Vancouver

Tian S, Zhao Y, Deng S, Hou L, Song J, Wang M, et al. Lupeol-3-carbamate Derivatives: Synthesis and Biological Evaluation as Potential Antitumor Agents. Molecules. 2024. doi:10.3390/molecules29173990

BibTeX
@article{Tian2024,
  author = {Tian, Shuang and Zhao, Yinxu and Deng, Siqi and Hou, Liman and Song, Juan and Wang, Ming and Bu, Ming},
  title = {Lupeol-3-carbamate Derivatives: Synthesis and Biological Evaluation as Potential Antitumor Agents},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29173990}
}
Kostenlos starten →